Clinicopathological and Molecular Study of Peritoneal Carcinomatosis Associated with Non-Small Cell Lung Carcinoma
- 12 August 2019
- journal article
- research article
- Published by Springer Nature in Pathology and Oncology Research
- Vol. 26 (4) , 2795-2800
Abstract
To retrospectively characterize the molecular features of Non-Small Cell Lung Carcinomas (NSCLC) with peritoneal carcinomatosis (PC), clinicopathological data of 12 patients diagnosed with NSCLC and PC between 2007 and 2016 were collected. Immunohistochemistry and Next Generation Sequencing (NGS) were performed on cases with available material. PC was the initial presentation of NSCLC in 17% of the cases. Overall, patients with PC displayed a poor median survival of 12 weeks. Histology was adenocarcinoma in 11 cases. 37.5% of cases showed PD-L1 immunostaining positivity (50% cut-off). ALK and ROS1 immunostainings were negative. Using NGS, we identified 17 molecular alterations in 9 genes (TP53, KRAS, STK11, BRAF, EGFR, DDR2, ERBB4, SMAD4, CTNNB1) in 88.9% of adenocarcinomas. To the best of our knowledge, 5 of these variants are not referenced in the literature. In conclusion, PC might be the initial presentation of NSCLC. Molecular profiling of our cases did not find any effective targetable alteration, except from high PD-L1 expression.Keywords
This publication has 17 references indexed in Scilit:
- Frequency of Somatic TP53 Mutations in Combination with Known Pathogenic Mutations in Colon Adenocarcinoma, Non–Small Cell Lung Carcinoma, and Gliomas as Identified by Next-Generation SequencingNeoplasia, 2018
- Malignant pleural disease is highly associated with subsequent peritoneal metastasis in patients with stage IV non-small cell lung cancer independent of oncogene statusLung Cancer, 2016
- Examining Treatment Outcomes with Erlotinib in Patients with Advanced Non–Small Cell Lung Cancer Whose Tumors Harbor Uncommon EGFR MutationsJournal of Thoracic Oncology, 2016
- KRAS mutant lung cancer: progress thus far on an elusive therapeutic targetClinical and Translational Medicine, 2015
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 2014
- Tumour heterogeneityNature, 2013
- Lung cancer and peritoneal carcinomatosisOncology Letters, 2013
- Peritoneal carcinomatosis in lung cancerRespirology, 2008
- Prognostic Factors for Gefitinib-Treated Postoperative Recurrence in Non-Small Cell Lung CancerOncology, 2007
- Small bowel metastases from primary carcinoma of the lungCancer, 1987